Ew. Willems et al., The role of several alpha(1)- and alpha(2)-adrenoceptor subtypes mediatingvasoconstriction in the canine external carotid circulation, BR J PHARM, 132(6), 2001, pp. 1292-1298
1 It has recently been shown that both alpha (1)- and alpha (2)-adrenocepto
rs mediate vasoconstriction in the canine external carotid circulation. The
present study set out to identify the specific subtypes (alpha (1A), alpha
(1B) and alpha (1D) as well as alpha (2A), alpha (2B) and alpha (2C)) medi
ating the above response.
2 Consecutive 1 min intracarotid infusions of phenylephrine (alpha (1)-adre
noceptor agonist) and BHT933 (alpha (2)-adrenoceptor agonist) produced dose
-dependent decreases in external carotid blood flow, without affecting mean
arterial blood pressure or heart rate.
3 The responses to phenylephrine were selectively antagonized by the antago
nists, 5-methylurapidil (alpha (1A)) or BMY7378 (alpha (1D)), but not by L-
765,314 (alpha (1B)), BRL44408 (alpha (2A)), imiloxan (alpha (2B)) or MK912
(alpha (2C)). In contrast, only BRL44408 or MK912 affected the responses t
o BHT933.
4 The above results support our contention that mainly the alpha (1A), alph
a (1D), alpha (2A) and alpha (2C)-adrenoceptor subtypes mediate vasoconstri
ction in the canine external carotid circulation.